F2G Ltd Announces the Appointment of Dr Richard J. White as Chairman of the Board of Directors

26-Feb-2010 - United Kingdom

F2G Limited, a Manchester UK based antifungal drug discovery and development company, announced the appointment of Dr Richard J. White as Chairman of the Company’s Board of Directors. Dr White has served as a non-executive director of F2G Ltd since April 2006.

F2G also announced the appointment of a new non-executive director, Dr Sten Verland of Sunstone Capital A/S.

"I congratulate Richard on his appointment as Chairman” said Shane M. Kelly, Chief Executive of F2G Ltd. “Richard has a wealth of experience in infectious disease drug discovery gained within Biotech and Pharma. He has been a tremendous asset to the Company during his time on the Board and I look forward to working with him towards the further development of F2G Ltd. The Board also welcomes Dr Sten Verland, whose proven expertise in building successful businesses will be a valuable addition to the team.”

Dr Richard J. White commented ”This an exciting time for F2G as our lead program progresses to clinical testing and I eagerly anticipate working closely with the other Board members".

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...